Researchers are investigating whether inflammation in the body, a side effect of ADT, contributes to these symptoms in prostate cancer patients. They pinpoint a specific inflammation marker that is associated with increased fatigue in this group of patients.
from Top Health News -- ScienceDaily https://ift.tt/3pKguN5
Post a Comment